Sarah J. Mancini
Glasgow, SCT G128QQ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery and Characterization of Novel Antagonists of the Proinflammatory Orphan Receptor GPR84.
Journal: ACS pharmacology & translational science
Published: June 04, 2021
A769662 Inhibits Insulin-Stimulated Akt Activation in Human Macrovascular Endothelial Cells Independent of AMP-Activated Protein Kinase.
Journal: International journal of molecular sciences
Published: November 16, 2018
On-target and off-target effects of novel orthosteric and allosteric activators of GPR84.
Journal: Scientific reports
Published: October 09, 2018
Investigating the Role of AMPK in Inflammation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 27, 2018
Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.
Journal: Scientific reports
Published: October 09, 2017
Activation of AMP-activated protein kinase rapidly suppresses multiple pro-inflammatory pathways in adipocytes including IL-1 receptor-associated kinase-4 phosphorylation.
Journal: Molecular and cellular endocrinology
Published: February 24, 2016
The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.
Journal: Diabetes
Published: January 12, 2016
Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation.
Journal: Clinical science (London, England : 1979)
Published: January 10, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026